Navre; Marc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Navre; Marc.The latest application filed is for "compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt".

Company Profile

3.15.19

Navre; Marc - Fremont CA
Navre; Marc - Belmont CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Grant 11,318,129 - Charmot , et al. May 3, 2	2022-05-03
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt App 20200268741 - Charmot; Dominique ; et al.	2020-08-27
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Grant 10,543,207 - Charmot , et al. Ja	2020-01-28
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt App 20190374533 - CHARMOT; Dominique ; et al.	2019-12-12
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders App 20170340623 - CHARMOT; Dominique ; et al.	2017-11-30
Compounds And Methods For Inhibiting Phosphate Transport App 20170037010 - Lewis; Jason G. ; et al.	2017-02-09
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorder Grant 9,408,840 - Bell , et al. August 9, 2	2016-08-09
Compounds and methods for inhibiting phosphate transport Grant 9,301,951 - Lewis , et al. April 5, 2	2016-04-05
Compounds and methods for inhibiting phosphate transport Grant 9,289,430 - Lewis , et al. March 22, 2	2016-03-22
Compounds and methods for inhibiting phosphate transport Grant 9,289,429 - Lewis , et al. March 22, 2	2016-03-22
Compounds and methods for inhibiting phosphate transport Grant 9,278,102 - Lewis , et al. March 8, 2	2016-03-08
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorder App 20150190389 - BELL; Noah ; et al.	2015-07-09
Compounds And Methods For Inhibiting Phosphate Transport App 20150164876 - Lewis; Jason G. ; et al.	2015-06-18
Compounds And Methods For Inhibiting Phosphate Transport App 20150164905 - Lewis; Jason G. ; et al.	2015-06-18
Compounds And Methods For Inhibiting Phosphate Transport App 20150164904 - Lewis; Jason G. ; et al.	2015-06-18
Compounds And Methods For Inhibiting Phosphate Transport App 20150157637 - Lewis; Jason G. ; et al.	2015-06-11
Non-systemic Tgr5 Agonists App 20150148311 - Lewis; Jason G. ; et al.	2015-05-28
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Grant 9,006,281 - Bell , et al. April 14, 2	2015-04-14
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Grant 8,969,377 - Bell , et al. March 3, 2	2015-03-03
Compounds and methods for inhibiting phosphate transport Grant 8,916,569 - Lewis , et al. December 23, 2	2014-12-23
Compounds and methods for inhibiting phosphate transport Grant 8,815,910 - Lewis , et al. August 26, 2	2014-08-26
Compounds and methods for inhibiting phosphate transport Grant 8,815,908 - Lewis , et al. August 26, 2	2014-08-26
Compounds and methods for inhibiting phosphate transport Grant 8,809,339 - Lewis , et al. August 19, 2	2014-08-19
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders App 20140107074 - BELL; Noah ; et al.	2014-04-17
Compounds And Methods For Inhibiting Phosphate Transport App 20140023611 - Lewis; Jason G. ; et al.	2014-01-23
Compounds And Methods For Inhibiting Phosphate Transport App 20130336918 - Lewis; Jason G. ; et al.	2013-12-19
Compounds And Methods For Inhibiting Phosphate Transport App 20130336919 - Lewis; Jason G. ; et al.	2013-12-19
Compounds And Methods For Inhibiting Phosphate Transport App 20130336921 - Lewis; Jason G. ; et al.	2013-12-19
Compounds And Methods For Inhibiting Phosphate Transport App 20130336920 - Lewis; Jason G. ; et al.	2013-12-19
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders App 20130274285 - BELL; Noah ; et al.	2013-10-17
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders Grant 8,541,448 - Charmot , et al. September 24, 2	2013-09-24
Compounds And Methods For Inhibiting Nhe-mediated Antiport In The Treatment Of Disorders Associated With Fluid Retention Or Salt Overload And Gastrointestinal Tract Disorders App 20120263670 - Charmot; Dominique ; et al.	2012-10-18
Assays for inhibitors of FtsH App 20030027251 - Das, Goutam ; et al.	2003-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.